Share

Society for Women’s Health Research Award Honors Teresa Woodruff

Teresa Woodruff, provost and executive vice president for Academic Affairs The Society for Women’s Health Research (SWHR) will honor Teresa Woodruff, PhD, with a Women’s Health Visionary Award for her contributions to women’s health research in endocrinology, ovarian biology, and reproductive science during its 35th Annual Awards Gala. Woodruff is also being honored for her leadership surrounding the sex as a biological variable policy within the...
Share

Classic Congenital Adrenal Hyperplasia Supplement Published in The Journal of Clinical Endocrinology & Metabolism

Last month, The Journal of Clinical Endocrinology and Metabolism published a classic congenital adrenal hyperplasia (CAH)-focused supplement, titled “Challenges and Opportunities in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Throughout the Lifetime.” The supplement contains eight review articles that provide a comprehensive look at the clinical, psychosocial, treatment-related and day-to-day challenges...
Share

McDonnell Receives 2025 Baxter Prize

Current McDonnell 2023 Headshot Donald Patrick McDonnell, PhD, has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the Society announced today.   The John D. Baxter Prize for Entrepreneurship was established to recognize the extraordinary achievement of bringing an idea, product, service, or process to market. This...
Share

Pharma Fridays — February 7, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves New Treatment Option For A Leading Cause of Diabetes-Related Blindness Genentech, a member of the Roche Group on February 4 announced that the U.S. Food and Drug Administration (FDA) approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of...
Share

Going With the Flow: MSEP Off to a Strong Start!

When the Endocrine Society launched its Medical School Engagement Program in 2024, it was an effort to increase the flow of endocrinologists into the workforce. Now, less than a year later, Endocrine News gets an exclusive update from some of the universities who have taken an active role in promoting endocrinology as a rewarding career...
Share

High Time: Addressing Research Gaps in Opioid-Associated Endocrine Conditions

Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare...
Share

Advocacy Update: February 2025

A monthly wrap-up of the Endocrine Society’s Advocacy efforts on behalf of the practice and science of endocrinology in the U.S. and around the world. Short-term Extension of SDP and Telehealth Waivers Signed into Law On December 21, 2024, President Biden signed into law a slimmed-down, temporary government spending bill to avoid a government shutdown....
Show More